Ischaemic colitis in a patient taking meloxicam

This publication has 5 references indexed in Scilit:

• COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin
  Gut, 2000
• Cyclooxygenase-2-derived prostaglandin D₂is an early anti-inflammatory signal in experimental colitis
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
• COX-2 inhibitors
  The Lancet, 1999
• A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy Volunteers
  Rheumatology, 1996
• Non-steroidal anti-inflammatory drugs and segmental non-gangrenous colitis
  European Journal of Gastroenterology & Hepatology, 1993